BLANDIZZI, CORRADO
BLANDIZZI, CORRADO
Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy)
2021 Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Blandizzi, C; Lucenteforte, E; Gini, R; Tuccori, M
Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study
2017 Galiulo M, Convertino I, Blandizzi C, Tassi R, Diacciati S, Nobili S, Capogrosso Sansone A, Marino A, Mini E, Mazzei T, Vannacci A, Parrilli M, Corona T, Tuccori M
Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy
2023 Convertino, Irma; Cazzato, Massimiliano; Tillati, Silvia; Giometto, Sabrina; Gini, Rosa; Valdiserra, Giulia; Cappello, Emiliano; Ferraro, Sara; Bonaso, Marco; Bartolini, Claudia; Paoletti, Olga; Lorenzoni, Valentina; Trieste, Leopoldo; Filippi, Matteo; Turchetti, Giuseppe; Cristofano, Michele; Blandizzi, Corrado; Mosca, Marta; Lucenteforte, Ersilia; Tuccori, Marco
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients
2020 Bertani L.; Baglietto L.; Antonioli L.; Fornai M.; Tapete G.; Albano E.; Ceccarelli L.; Mumolo M. G.; Pellegrini C.; Lucenteforte E.; de Bortoli N.; Bellini M.; Marchi S.; Blandizzi C.; Costa F.
Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope
2017 Pasqualetti, Giuseppe; Calsolaro, Valeria; Bini, Giacomo; Dell’agnello, Umberto; Tuccori, Marco; Marino, Alessandra; Capogrosso-sansone, Alice; Rafanelli, Martina; Santini, Massimo; Orsitto, Eugenio; Ungar, Andrea; Blandizzi, Corrado; Monzani, Fabio
Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship
2020 Lucarini E.; Parisio C.; Branca J.J.V.; Segnani C.; Ippolito C.; Pellegrini C.; Antonioli L.; Fornai M.; Micheli L.; Pacini A.; Bernardini N.; Blandizzi C.; Ghelardini C.; Di Cesare Mannelli L.
Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy
2021 Ferraro, S; Bartolini, C; Convertino, I; Bertani, L; Giometto, S; Cappello, E; Valdiserra, G; Tillati, S; Blandizzi, C; Lucenteforte, E; Costa, F; Gini, R; Tuccori, M
Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study
2021 Lorenzoni, V; Tuccori, M; Gini, R; Fini, E; Giometto, S; Bartolini, C; Paoletti, O; Convertino, I; Ferraro, S; Cappello, E; Valdiserra, G; Blandizzi, C; Lucenteforte, E; Turchetti, G
Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis
2023 Convertino, Irma; Lorenzoni, Valentina; Gini, Rosa; Turchetti, Giuseppe; Fini, Elisabetta; Giometto, Sabrina; Bartolini, Claudia; Paoletti, Olga; Ferraro, Sara; Cappello, Emiliano; Valdiserra, Giulia; Bonaso, Marco; Blandizzi, Corrado; Tuccori, Marco; Lucenteforte, Ersilia
Hepatitis C virus infection: opportunities for an earlier detection in primary care
2016 Lapi, F; Capogrosso Sansone, A; Mantarro, S; Simonetti, M; Tuccori, M; Blandizzi, C; Rossi, A; Corti, G; Bartoloni, A; Bellia, A; Baiocchi, L; Cricelli, I; Cricelli, C
Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy
2021 Giometto, S; Convertino, I; Tuccori, M; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Turchetti, G; Trieste, L; Lorenzoni, V; Blandizzi, C; Mosca, M; Lucenteforte, E
Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact
2019 Convertino, I; Lucenteforte, E; Lorenzoni, V; Turchetti, G; Trieste, L; Roberto, G; Cazzato, M; Mosca, M; Ferraro, S; Leonardi, L; Luciano, N; Gini, R; Blandizzi, C; Tuccori, M
Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy
2019 Convertino, I; Tuccori, M; Lucenteforte, E; Mosca, M; Turchetti, G; Lorenzoni, V; Trieste, L; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R
The Anti-TNF Drugs and the Risk of Lymphoma, Skin Cancer and Melanoma: A Signal Detection Analysis
2019 Leonardi, L; Fornili, M; Convertino, I; Lucenteforte, E; Del Lungo, M; Ferraro, S; Blandizzi, C; Giovannetti, L; Baglietto, L; Parrilli, M; Borsi, V; Di Giorgio, D
THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES
2019 Lorenzoni, V; Convertino, I; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Cazzato, M; Blandizzi, C; Gini, R; Tuccori, M; Mosca, M; Turchetti, G
The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy
2019 Lorenzoni, V; Trieste, L; Mosca, M; Convertino, I; Tuccori, M; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R; Turchetti, G
Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database
2020 Ferraro, S; Bartolini, C; Bertani, L; Convertino, I; Lucenteforte, E; Costa, F; Valdiserra, G; Cappello, E; Blandizzi, C; Gini, R; Tuccori, M
Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study
2021 Convertino I.; Giometto S.; Gini R.; Cazzato M.; Fornili M.; Valdiserra G.; Cappello E.; Ferraro S.; Bartolini C.; Paoletti O.; Tillati S.; Baglietto L.; Turchetti G.; Trieste L.; Lorenzoni V.; Blandizzi C.; Mosca M.; Tuccori M.; Lucenteforte E.
Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy)
2021 Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Lucenteforte, E; Cappello, E; Valdiserra, G; Blandizzi, C; Gini, R; Tuccori, M
Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy
2020 Convertino, I; Giometto, S; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Fornili, M; Turchetti, G; Lorenzoni, V; Trieste, L; Mosca, M; Blandizzi, C; Tuccori, M; Lucenteforte, E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Adherence to mesalazine and identification of patients with ulcerative colitis in healthcare administrative databases of Tuscany (Italy) | 2021 | Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Blandizzi, C; Lucenteforte, E; Gini, R; Tuccori, M | |
| Adverse drug reactions in oncoLogy: intEnsive monitoring program on drug toXicity of biotechnological medicatioNs anD taRget therapies in Oncologic patientS - the ALEXANDROS observational study | 2017 | Galiulo M, Convertino I, Blandizzi C, Tassi R, Diacciati S, Nobili S, Capogrosso Sansone A, Marino A, Mini E, Mazzei T, Vannacci A, Parrilli M, Corona T, Tuccori M | |
| Assessing disease activity of rheumatoid arthritis patients and drug-utilization patterns of biologic disease-modifying antirheumatic drugs in the Tuscany region, Italy | 2023 | Convertino, Irma; Cazzato, Massimiliano; Tillati, Silvia; Giometto, Sabrina; Gini, Rosa; Valdiserra, Giulia; Cappello, Emiliano; Ferraro, Sara; Bonaso, Marco; Bartolini, Claudia; Paoletti, Olga; Lorenzoni, Valentina; Trieste, Leopoldo; Filippi, Matteo; Turchetti, Giuseppe; Cristofano, Michele; Blandizzi, Corrado; Mosca, Marta; Lucenteforte, Ersilia; Tuccori, Marco | |
| Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients | 2020 | Bertani L.; Baglietto L.; Antonioli L.; Fornai M.; Tapete G.; Albano E.; Ceccarelli L.; Mumolo M. G.; Pellegrini C.; Lucenteforte E.; de Bortoli N.; Bellini M.; Marchi S.; Blandizzi C.; Costa F. | |
| Clinical differences among the elderly admitted to the emergency department for accidental or unexplained falls and syncope | 2017 | Pasqualetti, Giuseppe; Calsolaro, Valeria; Bini, Giacomo; Dell’agnello, Umberto; Tuccori, Marco; Marino, Alessandra; Capogrosso-sansone, Alice; Rafanelli, Martina; Santini, Massimo; Orsitto, Eugenio; Ungar, Andrea; Blandizzi, Corrado; Monzani, Fabio | |
| Deepening the Mechanisms of Visceral Pain Persistence: An Evaluation of the Gut-Spinal Cord Relationship | 2020 | Lucarini E.; Parisio C.; Branca J.J.V.; Segnani C.; Ippolito C.; Pellegrini C.; Antonioli L.; Fornai M.; Micheli L.; Pacini A.; Bernardini N.; Blandizzi C.; Ghelardini C.; Di Cesare Mannelli L. | |
| Diagnostic delay, effectiveness and safety outcomes in a real-world cohort of patients with Crohn's disease: Data from administrative databases in Tuscany, Italy | 2021 | Ferraro, S; Bartolini, C; Convertino, I; Bertani, L; Giometto, S; Cappello, E; Valdiserra, G; Tillati, S; Blandizzi, C; Lucenteforte, E; Costa, F; Gini, R; Tuccori, M | |
| Direct health care costs among patients with rheumatoid arthritis before and after the initiation of treatment with JAKi in Tuscany: The LEONARDO study | 2021 | Lorenzoni, V; Tuccori, M; Gini, R; Fini, E; Giometto, S; Bartolini, C; Paoletti, O; Convertino, I; Ferraro, S; Cappello, E; Valdiserra, G; Blandizzi, C; Lucenteforte, E; Turchetti, G | |
| Drug-Utilization, Healthcare Facilities Accesses and Costs of the First Generation of JAK Inhibitors in Rheumatoid Arthritis | 2023 | Convertino, Irma; Lorenzoni, Valentina; Gini, Rosa; Turchetti, Giuseppe; Fini, Elisabetta; Giometto, Sabrina; Bartolini, Claudia; Paoletti, Olga; Ferraro, Sara; Cappello, Emiliano; Valdiserra, Giulia; Bonaso, Marco; Blandizzi, Corrado; Tuccori, Marco; Lucenteforte, Ersilia | |
| Hepatitis C virus infection: opportunities for an earlier detection in primary care | 2016 | Lapi, F; Capogrosso Sansone, A; Mantarro, S; Simonetti, M; Tuccori, M; Blandizzi, C; Rossi, A; Corti, G; Bartoloni, A; Bellia, A; Baiocchi, L; Cricelli, I; Cricelli, C | |
| Longitudinal adherence trajectories to biologic disease modifying anti-rheumatic drugs in Tuscany, Italy | 2021 | Giometto, S; Convertino, I; Tuccori, M; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Tillati, S; Fornili, M; Bartolini, C; Paoletti, O; Turchetti, G; Trieste, L; Lorenzoni, V; Blandizzi, C; Mosca, M; Lucenteforte, E | |
| Recommendations by the Tuscan Health Authority to Use Infliximab-Biosimilar in the Clinical Practice: Safety Impact | 2019 | Convertino, I; Lucenteforte, E; Lorenzoni, V; Turchetti, G; Trieste, L; Roberto, G; Cazzato, M; Mosca, M; Ferraro, S; Leonardi, L; Luciano, N; Gini, R; Blandizzi, C; Tuccori, M | |
| Switching from infliximab-originator to infliximab-biosimilar in rheumatologic patients: The clinical impact in Tuscan Region, Italy | 2019 | Convertino, I; Tuccori, M; Lucenteforte, E; Mosca, M; Turchetti, G; Lorenzoni, V; Trieste, L; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R | |
| The Anti-TNF Drugs and the Risk of Lymphoma, Skin Cancer and Melanoma: A Signal Detection Analysis | 2019 | Leonardi, L; Fornili, M; Convertino, I; Lucenteforte, E; Del Lungo, M; Ferraro, S; Blandizzi, C; Giovannetti, L; Baglietto, L; Parrilli, M; Borsi, V; Di Giorgio, D | |
| THE ECONOMIC IMPACT OF THE INTRODUCTION OF INFLIXIMAB-BIOSIMILAR: AN EMPIRICAL ANALYSIS USING THE TUSCANY HEALTHCARE ADMINISTRATIVE DATABASES | 2019 | Lorenzoni, V; Convertino, I; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Cazzato, M; Blandizzi, C; Gini, R; Tuccori, M; Mosca, M; Turchetti, G | |
| The Economic Impact of the Introduction of Infliximab-Biosimilar: Preliminary Results from a Study on Rheumatologic Patients in Tuscany, Italy | 2019 | Lorenzoni, V; Trieste, L; Mosca, M; Convertino, I; Tuccori, M; Lucenteforte, E; Ferraro, S; Leonardi, L; Roberto, G; Luciano, N; Blandizzi, C; Gini, R; Turchetti, G | |
| Time to biologic treatment and to total colectomy associated with diagnostic delay in ulcerative colitis: Analysis of an Italian regional administrative healthcare database | 2020 | Ferraro, S; Bartolini, C; Bertani, L; Convertino, I; Lucenteforte, E; Costa, F; Valdiserra, G; Cappello, E; Blandizzi, C; Gini, R; Tuccori, M | |
| Trajectories of adherence to biologic disease-modifying anti-rheumatic drugs in tuscan administrative databases: The pathfinder study | 2021 | Convertino I.; Giometto S.; Gini R.; Cazzato M.; Fornili M.; Valdiserra G.; Cappello E.; Ferraro S.; Bartolini C.; Paoletti O.; Tillati S.; Baglietto L.; Turchetti G.; Trieste L.; Lorenzoni V.; Blandizzi C.; Mosca M.; Tuccori M.; Lucenteforte E. | |
| Trajectories of oral budesonide use in Crohn's disease cohort of Tuscan patients (Italy) | 2021 | Bartolini, C; Ferraro, S; Convertino, I; Bertani, L; Giometto, S; Costa, F; Lucenteforte, E; Cappello, E; Valdiserra, G; Blandizzi, C; Gini, R; Tuccori, M | |
| Trajectories of use of biologic disease modifying antirheumatic drugs in rheumatoid arthritis: A cohort study of Tuscan patients, Italy | 2020 | Convertino, I; Giometto, S; Gini, R; Cazzato, M; Valdiserra, G; Cappello, E; Ferraro, S; Fornili, M; Turchetti, G; Lorenzoni, V; Trieste, L; Mosca, M; Blandizzi, C; Tuccori, M; Lucenteforte, E |